Drugs that contain Letermovir

1. Drug name - PREVYMIS

Patent Number Company Patent Title Patent Expiry Activity Alert
These patents protects the active chemical substance. Only patent owner can launch products that use this active substance.
US8513255 MERCK SHARP DOHME Substituted dihydroquinazolines
May, 2024

(1 year, 7 months from now)

USRE46791 MERCK SHARP DOHME Substituted dihydroquinazolines
May, 2024

(1 year, 7 months from now)

CN100393706C MERCK SHARP DOHME Substituted Dihydroquinazolin Having Anti-Virus Capability
Apr, 2024

(1 year, 6 months from now)

CN1784390A MERCK SHARP DOHME Substituted Dihydroquinazolin Having Anti-Virus Capability
Apr, 2024

(1 year, 6 months from now)

IN200504403P1 MERCK SHARP DOHME Substituted Dihydroquinazolines
Apr, 2024

(1 year, 6 months from now)

IN230768B MERCK SHARP DOHME Substituted Dihydroquinazoline Compounds
Apr, 2024

(1 year, 6 months from now)

EP1622880B3 MERCK SHARP DOHME Substituted Dihydrochinazolines Having Antiviral Properties
Apr, 2024

(1 year, 6 months from now)

EP1622880A1 MERCK SHARP DOHME Substituted Dihydrochinazolines Having Antiviral Properties
Apr, 2024

(1 year, 6 months from now)

EP1622880B1 MERCK SHARP DOHME Substituted Dihydrochinazolines Having Antiviral Properties
Apr, 2024

(1 year, 6 months from now)

These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US10603384 MERCK SHARP DOHME Pharmaceutical composition containing an antivirally active dihydroquinazoline derivative Feb, 2033

(10 years from now)

Treatment: NA

Dosage: SOLUTION;INTRAVENOUS

More Information on Dosage
Strength Dosage Availability
240MG/12ML (20MG/ML) SOLUTION;INTRAVENOUS Prescription
480MG/24ML (20MG/ML) SOLUTION;INTRAVENOUS Prescription

availability in other generic markets.

Click on the highlighted region to filter.